SAIC · Science Applications International Corp
$126.68
+0.02 (+0.02%)
At close · Aug 14
Market Cap
$5.36B
Shares
42.28M
Price & Indicators
20d MA
50d MA
200d MA
Earnings
Filing
Insider
Congress
Investor day
Close$126.68
Open$126.92
Day$124.59–127.09
52W close$82.22–126.68
Avg vol 30d413K
Short int2.4M · 5.6% float · 5.6d
Short vol56%
Last earningsJun 1, 2026
DataJan 2020–Aug 2026
Filing10-Q · Jun 1
Up next
Next earnings call
Sep 2, 2026
Est · unconfirmed
· in 2 wks
FQ3-27 quarter ends
~Oct 29, 2026
Est
filed Jun 1, 2026
AI Brief
TL;DR.
Bullish
Bearish
From the call
AI-generated from the earnings call and 8-K · may contain errors · not investment advice
Ask ALVIS about this →Equibles Rating
blended score · not investment adviceOverall
Buy
SellHoldBuy
Technical
Strong Buy
Momentum
Very Strong
Sentiment
Bullish
Fundamentals
Strong
Quant / Vol
Moderate
Market backdrop
VIX 14.3 · calm
Equity put/call 0.52
Technical
price trend
50 / 200-day cross
No cross
Price vs 200-day avg
+25%
above
Price vs 50-day avg
+10%
above
RSI (14)
68
neutral
MACD trend
Positive
52-week position
100%
near high
Volume (OBV)
Confirms
volume backs price
Momentum
relative strength
1-month return
+10%
trailing
6-month return
+47%
trailing
YTD return
+26%
this year
Relative strength
+33%
vs S&P · 6-mo
Sentiment
smart money
Trend (MA cross)
No cross
50d $115 › 200d $101 — 50d above 200d
Institutional flow
Accumulating
+0% holders QoQ · +62 funds added
Insider flow
Flat
No net insider activity over 90 days
Short interest
Falling
5.61% of float · ▼ -20.0% MoM · 5.6 days cover
Volume signal
Normal
Volume near normal
Institution breadth
Steady
425 holders — mid 3-yr range
Squeeze score
68
elevated · 0–100
Fundamentals
Revenue growth
−3%
Y/Y
EPS growth
+7%
Y/Y
Free cash flow
$577.0M
Valuation
P/E 14.3
below peers
Buyback
$4.1B
authorized
Balance sheet
$2.3B
net debt
Quant / Vol
risk profile
Volatility
40%
annualized · 1-yr
Max drawdown
−31%
past year
ATR
2.9%
of price · 14-day
Blended from price, momentum, positioning, fundamentals & volatility · daily-close · not investment advice. Market backdrop is context, not part of the score.
Guidance & track record
Latest guidance
· from the 8-K filed Jun 1, 2026
Revenue
· Fiscal Year 2027
$7B – $7.2B
Organic Growth
· Fiscal Year 2027
-4% – -2%
Adjusted EBITDA
· Fiscal Year 2027
Non-GAAP
$720M – $730M
Adjusted EBITDA Margin %
· Fiscal Year 2027
Non-GAAP
10.1% – 10.3%
Adjusted Diluted EPS
· Fiscal Year 2027
Non-GAAP
$9.90 – $10.10
Free Cash Flow
· Fiscal Year 2027
Non-GAAP
at least $600M
Prior guidance
period ended
· from the Earnings Call filed Jul 31, 2024
Bid submissions
· full year
$22B
Guided vs delivered
· last 2 settled
Revenue
Fiscal Year 2026 Guidance
guided $7.28B – $7.33B
$7.26B
Miss −0.5%
Revenue
fiscal year 2025
guided $7.35B – $7.5B
$7.48B
In line
Guidance from company 8-Ks · delivered figures from as-reported statements · no analyst estimates involved.
Technicals
trend & momentum for long-term holders Strong Buy
50 / 200-day cross
No cross
Neutral
Price vs 200-day avg
+25%
Bullish
Price vs 50-day avg
+10%
Bullish
RSI (14)
68
Neutral
MACD trend
Positive
Bullish
52-week position
100%
Bullish
Volume (OBV)
Confirms
Neutral
Market signals — smart money & positioning
Bullish · 2 of 6
Trend (MA cross)
No cross
50d $115 › 200d $101 — 50d above 200d
Institutional flow
Accumulating
+0% holders QoQ · +62 funds added
Insider flow
Flat
No net insider activity over 90 days
Short interest
Falling
5.61% of float · ▼ -20.0% MoM · 5.6 days cover
Volume signal
Normal
Volume near normal
Institution breadth
Steady
425 holders — mid 3-yr range
Price context
position in its 52-week range
Range low $82
Now $127 · 100%
Range high $127
vs 200-day avg +25%
vs 50-day avg +10%
Illustrative technical + ownership context — a signal mix, not investment advice.
Key metrics
the company's own KPIs, from written earnings releases and filings| Metric | Latest | Period | YoY |
|---|---|---|---|
| Adjusted EBITDA non-GAAP | $222M | Q1 FY2027 | — |
|
|
|||
GAAP → non-GAAP reconciliationGAAP EBITDA 220M
+2M Acquisition, integration, restructuring and impairment costs
-1M Recovery of acquisition, integration, restructuring and impairment costs
+1M Costs related to the settlement of federal tax audits
= Adjusted EBITDA 222M
|
|||
| Adjusted EBITDA as a percentage of revenues non-GAAP | 11.6% | Q1 FY2027 | — |
| Book-to-bill ratio | 1.1 | Q1 FY2027 | — |
|
|
|||
| estimated backlog | 22.9B | Q1 FY2027 | — |
| Free cash flow non-GAAP | $118M | Q1 FY2027 | — |
GAAP → non-GAAP reconciliationGAAP Net cash provided by operating activities 127M
-9M Expenditures for property, plant, and equipment
+0M Cash used from (provided by) MARPA Facility
= Free cash flow 118M
|
|||
| funded backlog | 3.7B | Q1 FY2027 | — |
| Net bookings | 2.1B | Q1 FY2027 | — |
|
|
|||
| Share repurchases | $175M | Q1 FY2027 | — |
| Trailing twelve months book-to-bill ratio | 1.1 | FY26 | — |
| Adjusted EBITDA Margin % non-GAAP | 10.3% | Q4 FY26 | — |
Figures exactly as the company stated them in writing · click a metric with a to chart its history · period links open the stating document · "filing" marks figures stated in the 10-K/10-Q · YoY needs an exactly comparable prior-year period
Versus peers
Information Technology Services — same industry group| Company | Mkt cap | YTD | Rev growth Y/Y | P/E | Short % shares |
|---|---|---|---|---|---|
|
SAIC
this stock
Science Applications International Corp
|
$5.36B | +25.8% | -2.9% | 14.3 | 5.6% |
|
IBM
International Business Machines Corp
|
$220.76B | -20.9% | +7.6% | 20.8 | 2.4% |
|
ACN
Accenture plc
|
$118.13B | -34.1% | +7.4% | 14.1 | 4.9% |
|
INFY
Infosys Ltd
|
$48.97B | -32.2% | — | — | 3.6% |
|
CTSH
Cognizant Technology Solutions Corp
|
$27.86B | -29.2% | +7.0% | 12.8 | 9.5% |
Peers by industry group · P/E from as-reported trailing EPS · short % is of shares outstanding
At a glance
key data from every sectionOwnership
Short & Settlement
Smart Money
Financials
Filings
Earnings & Events
Performance
| 5D | 20D | 120D | MTD | YTD | |
|---|---|---|---|---|---|
| SAIC | +0.1% | +9.7% | +46.6% | +8.2% | +25.9% |
| SPY | +0.4% | +4.5% | +13.8% | +3.9% | +13.9% |
| vs SPY | -0.3% | +5.2% | +32.8% | +4.2% | +12.0% |
Capital returns
Latest dividend
$0.37
/ share · ex Jul 10, 2026
Paid (TTM)
$1.48
/ share · 4 payouts
Dividend yield (TTM, derived)
1.17%
Buyback programs
· 3 active
· as of May 1, 2026
Authorized (total)
$4.08B
Spent (derived)
—
Remaining
—
Dividends per share over the trailing 365 days by ex-date · buyback figures as last reported in SEC filings ("spent" derived as authorized − remaining; when several programs run concurrently, authorized is their combined total per the newest filing) · components shown separately — trailing-year buyback spend isn't tracked, so no combined shareholder yield is derived.
Key facts
CIK
1571123
CUSIP
808625107
13F (30d)
395 filings
386 filers
Visit website
Investor relations